In 2016, while Arizona voters were deciding on Proposition 205 — a ballot measure to legalize recreational cannabis — a pharmaceutical company called Insys Therapeutics quietly donated $500,000 to the opposition campaign. That half-million dollars made Insys the single largest donor fighting to keep weed illegal in Arizona.
Their sole product? Subsys, a sublingual fentanyl spray that was generating $62 million in revenue per quarter. In their own SEC filings, Insys admitted their concern: legalization of cannabis “could significantly limit the commercial success of any opioid product.”
Read that again. A fentanyl manufacturer — the company making the exact drug that was killing tens of thousands of Americans every year — spent half a million dollars to make sure you couldn’t legally buy a plant.
The Conviction
The story doesn’t end with a political donation. It ends in a federal courtroom.
In 2019, seven Insys executives were convicted of racketeering conspiracy — the same charge typically reserved for organized crime. The DOJ proved that Insys had systematically bribed doctors to prescribe Subsys to patients who didn’t need it, including patients who didn’t even have cancer (the drug was only approved for breakthrough cancer pain).
Founder and former CEO John Kapoor was sentenced to 66 months in federal prison. The company paid a $225 million settlement and filed for bankruptcy. Multiple doctors who took the bribes also went to prison.
The scheme was breathtaking in its brazenness. Insys sales reps hosted “speaker programs” that were actually lavish dinners designed to reward high-prescribing doctors. They hired a stripper-turned-sales-rep who literally gave a doctor a lap dance to secure prescriptions. They created a fraud unit internally — not to prevent fraud, but to lie to insurance companies to get prior authorizations approved.
People died. The fentanyl spray they were pushing killed patients who never should have been prescribed it.
The Patent That Proves the Lie
Here’s where it gets truly obscene. While the federal government classifies cannabis as Schedule I — “no currently accepted medical use” — the U.S. Department of Health and Human Services holds Patent 6,630,507, titled “Cannabinoids as antioxidants and neuroprotectants.”
The patent, granted in 2003, specifically claims that cannabinoids are useful in treating “oxidative associated diseases” including ischemic, age-related, inflammatory, and autoimmune diseases. The federal government literally owns a patent on the medical use of a substance it says has no medical use.
That’s not an oversight. That’s a policy choice. And the people who benefit from that choice have spent fortunes making sure it stays that way.
Follow the Money — $6.1 Billion in Lobbying
Insys wasn’t an outlier. They were just the ones who got caught being criminals about it.
Since 1999, the pharmaceutical industry has spent more than $6.1 billion on lobbying — more than any other industry in America, according to OpenSecrets data. That’s not campaign donations. That’s paying people to sit in congressional offices and shape drug policy.
Why do they care so much about cannabis? Because a landmark 2019 study published in PLOS ONE found that each state that legalizes medical cannabis costs pharmaceutical companies approximately $3 billion in annual sales. Cannabis directly replaces prescription drugs — pain medications, sleep aids, anti-anxiety pills, and yes, opioids.
A 2017 study published in the Journal of Pain and covered by Harvard Health found that 77% of opioid users significantly reduced their opioid use after starting medical cannabis treatment. Some eliminated opioids entirely.
Think about what those numbers mean. Every state legalization is a multi-billion-dollar hit to an industry that has spent decades building the most powerful lobbying operation in Washington.
700,000 Dead and Counting
While pharma companies lobbied to keep cannabis illegal, the opioid crisis they created has killed more than 700,000 Americans, according to the National Institute on Drug Abuse (NIDA). Fentanyl — the exact drug Insys was bribing doctors to overprescribe — is now the leading cause of death for Americans aged 18-45.
Let me put this in perspective. The drug war is the longest-running war in American history — over 50 years and counting. And for most of that time, the federal government has been protecting the companies selling the drugs that actually kill people while criminalizing the plant that could save them.
Cannabis has never caused a fatal overdose. Not once. Not ever. Fentanyl kills roughly 200 Americans every single day.
Insys Therapeutics donated $500,000 to keep cannabis illegal, then got convicted as a criminal enterprise for pushing the deadliest drug in America. Their founder went to prison. Their company went bankrupt. And the policy they paid to preserve — cannabis prohibition — is still largely in place at the federal level.
That’s not a war on drugs. That’s a protection racket.
Sources
- Phoenix New Times — Insys Therapeutics Anti-Pot Crusade Exposed by DOJ Prosecution
- The Intercept — Fentanyl Maker Donates $500,000 to Defeat Marijuana Legalization
- DOJ — John Kapoor Sentenced to 66 Months
- PLOS ONE — US Cannabis Laws and Pharmaceutical Sales (2019)
- Harvard Health — Medical Marijuana and Opioid Use Reduction
- NIDA — Overdose Death Rates
- OpenSecrets — Pharmaceutical Industry Lobbying
- U.S. Patent 6,630,507 — Cannabinoids as Antioxidants and Neuroprotectants